Frequency of acromegaly in adults with diabetes or glucose intolerance and estimated prevalence in the general population

Pituitary

Volumn 14, Issue 3, 2011, Pages 217-221

  Rosario, Pedro Weslley ^a,b  

^a Postgraduation Program   (Brazil)

^b NONE   (Brazil)

Author keywords

Acromegaly; Diabetes; Glucose intolerance; Prevalence

Indexed keywords

GLUCOSE; GROWTH HORMONE; OCTREOTIDE; SOMATOMEDIN C;

ACROMEGALY; ADULT; AGED; ARTICLE; BRAZIL; COMORBIDITY; FEMALE; GLUCOSE INTOLERANCE; HORMONE BLOOD LEVEL; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; IMMUNOHISTOCHEMISTRY; INSULIN LIKE GROWTH FACTOR 1 BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL GLUCOSE TOLERANCE TEST; PREVALENCE; PRIORITY JOURNAL; TRANSSPHENOIDAL SURGERY;

ACROMEGALY; ADULT; AGED; DIABETES MELLITUS; FEMALE; GLUCOSE INTOLERANCE; HUMANS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 80053927915     PISSN: 1386341X     EISSN: 15737403     Source Type: Journal    
DOI: 10.1007/s11102-010-0281-0     Document Type: Article

References (35)

1. Melmed S (2006) Medical progress: acromegaly. N Engl J Med 355:2558-2573
2. Buurman H, Saeger W (2006) Subclinical adenomas in postmortem pituitaries: classification and correlations to clinical data. Eur J Endocrinol 154:753-758 (Pubitemid 43810863)
3. Tomita T, Gates E (1999) Pituitary adenomas and granular cell tumors. Incidence, cell type, and location of tumor in 100 pituitary glands at autopsy. Am J Clin Pathol 111:817-825 (Pubitemid 29250113)
4. Coulon G, Fellmann D, Arbez-Gindre F, Pageaut G (1983) Latent pituitary adenoma. Autopsy study. Sem Hop 59:2747-2750 (Pubitemid 14239631)
5. Kim JH, Seo JS, Lee BW, Lee SY, Jeon SH, Lee KB (2007) The characteristics of incidental pituitary microadenomas in 120 Korean forensic autopsy cases. J Korean Med Sci 22(Suppl):S61-S65
6. Daly AF, Rixhon M, Adam C, Dempegioti A, Tichomirowa MA, Beckers A (2006) High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. J Clin Endocrinol Metab 91:4769-4775 (Pubitemid 44917305)
7. Cannavó S, Ferraú F, Ragonese M, Curtó L, Torre ML, Magistri M, Marchese A, Alibrandi A, Trimarchi F (2010) Increased prevalence of acromegaly in a highly polluted área. Eur J Endocrinol 163:509-513
8. Schneider HJ, Sievers C, Saller B, Wittchen HU, Stalla GK (2008) High prevalence of biochemical acromegaly in primary care patients with elevated IGF-1 levels. Clin Endocrinol (Oxf) 69:432-435
9. Reid TJ, Post KD, Bruce JN, Nabi Kanibir M, Reyes-Vidal CM, Freda PU (2010) Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006; acromegaly remains under-recognized and under-diagnosed. Clin Endocrinol (Oxf) 72:203-208
10. Psaras T, Milian M, Hattermann V, Freiman T, Gallwitz B, Honegger J (2010) Demographic factors and the presence of comorbidities do not promote early detection of Cushing's disease and acromegaly. Exp Clin Endocrinol Diabetes. doi: 10.1055/s-0030-1263104
11. Colao A, Ferone D, Marzullo P, Lombardi G (2004) Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 25:102-152 (Pubitemid 38269977)
12. Molitch ME (1992) Clinical manifestations of acromegaly. Endocrinol Metab Clin N Am 21:597-614
13. Biering H, Knappe G, Gerl H (2000) Prevalence of diabetes in acromegaly and Cushing syndrome. Acta Med Aust 27:27-31
14. Colao A, Baldelli R, Marzullo P (2000) Systemic hypertension and impaired glucose tolerance are independently correlated to the severity of the acromegalic cardiomyopathy. J Clin Endo-crinol Metab 85:193-199 (Pubitemid 32268813)
15. Ezzat S, Forster MJ, Berchtold P (1994) Acromegaly: clinical and biochemical features in 500 patients. Medicine 73:233-240
16. Mercado M, Espinosa de los Monteros AL, Sosa E (2004) Clinical-biochemical correlations in acromegaly at diagnosis and the real prevalence of biochemically discordant disease. Horm Res 62:293-299 (Pubitemid 40069628)
17. Mestron A, Webb SM, Astorga R (2004) Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Español de Acromegalia, REA). Eur J Endocrinol 151:439-446 (Pubitemid 39430260)
18. Tanimoto K, Hizuka N, Fukuda I, Takano K, Hanafusa T (2008) The influence of age on the GH-IGF1 axis in patients with acromegaly. Eur J Endocrinol 159:375-379
19. Donangelo I, Une K, Gadelha M (2003) Diagnosis and treatment of acromegaly in Brazil. Arq Bras Endocrinol Metab 47:331-346
20. Malerbi D, Franco LJ (1992) The Brazilian Cooperative Group on the Study of Diabetes Prevalence. Multicenter study of the prevalence of diabetes mellitus and impaired glucose tolerance in the urban Brazilian population aged 30-69 years. Diabetes Care 15:1509-1516
21. Torquato MT, Montenegro RN Jr, Viana LAL (2003) Prevalence of diabetes mellitus and impaired glucose tolerance in the urban population aged 30-69 years in Ribeirão Preto (São Paulo), Brazil. São Paulo Med J 121:224-230 (Pubitemid 38016169)
22. www.diabetesatlas.org/content/diabetes-and-impaired-glucose-tolerance
23. American Diabetes Association (2009) Diagnosis and classification of diabetes mellitus. Diabetes Care 32(suppl 1):S62-S67
24. Rosario PW (2010) Normal values of serum IGF-1 in adults: results from a Brazilian population. Arq Bras Endocrinol Metab 54:477-481
25. Rosario PW, Furtado M (2008) Growth hormone after oral glucose overload: revision of reference values in normal subjects. Arq Bras Endocrinol Metab 52:1139-1144
26. Freda P (2004) Acromegaly - diagnostic pitfalls. The Endocri-nologist 14:277-287
27. Freda PU (2009) Monitoring of acromegaly: what should be performed when GH and IGF-1 levels are discrepant? Clin Endocrinol (Oxf) 71:166-170
28. Dimaraki EV, Jaffe CA, DeMott-Friberg R, Chandler WF, Bar-kan AL (2002) Acromegaly with apparently normal GH secretion: implications for diagnosis and follow-up. J Clin Endocrinol Metab 87:3537-3542 (Pubitemid 34879493)
29. Freda PU, Reyes CM, Nuruzzaman AT, Sundeen RE, Bruce JN (2003) Basal and glucose-suppressed GH levels less than 1 microg/L in newly diagnosed acromegaly. Pituitary 6:175-180 (Pubitemid 39127616)
30. Doppman JL, Miller DL, Patronas NJ, Oldfield EH, Merriam GR, Frank SJ, Flack MR, Weintraub BD, Gorden P (1990) The diagnosis of acromegaly: value of inferior petrosal sinus sampling. AJR Am J Roentgenol 154:1075-1077 (Pubitemid 20133967)
31. Daud S, Hamrahian AH, Weil RJ, Hamaty M, Prayson RA, Olansky L (2010) Acromegaly with negative pituitary MRI and no evidence of ectopic source: the role of transphenoidal pituitary exploration? Pituitary doi:10.1007/s11102-009- 0205-z
32. Lonser RR, Kindzelski BA, Mehta GU, Jane JA Jr, Oldfield EH (2010) Acromegaly without imaging evidence of pituitary adenoma. J Clin Endocrinol Metab. doi:10.1210/jc.2010-0570
33. Lim DJ, Kwon HS, Cho JH, Kim SH, Choi YH, Yoon KH, Cha BY, Lee KW, Son HY, Kang SK (2007) Acromegaly associated with type 2 diabetes showing normal IGF-1 levels under poorly controlled glycemia. Endocr J 54:537-541 (Pubitemid 47414600)
34. Arihara Z, Sakurai K, Yamada S, Murakami O, Takahashi K (2008) Acromegaly with normal IGF-1 levels probably due to poorly controlled diabetes mellitus. Tohoku J Exp Med 216:325-329
35. Melmed S (2001) Acromegaly and cancer: not a problem. J Clin Endocrinol Metab 86:2929-2934